COL18A1 and non-small cell lung carcinoma: From the anti-tumor effect, zinc binding recombinant endostatin in the N-terminus (ZBP-endostatin; its trade name is Endostar) is approved by the State Food and Drug Administration of China for the treatment of non-small-cell lung cancer [19].